RSF1 and neoplasm: Conversely, RSF1 (Remodeling and Spacing Factor 1) gain of function is observed in a variety of human cancers, and is directly associated with tumor aggressiveness, poor therapeutic response, reduced survival, and poor prognosis [66,67,68].